Department of Anesthesiology and Intensive Care and Department of Medical and Health Sciences, Linköping University, Norrköping, Sweden.
Department of Thoracic and Vascular Surgery and Department of Medical and Health Sciences, Linköping University, Linköping, Sweden.
Crit Care. 2022 Sep 4;26(1):264. doi: 10.1186/s13054-022-04122-w.
COVID-19 ARDS shares features with non-COVID ARDS but also demonstrates distinct physiological differences. Despite a lack of strong evidence, prone positioning has been advocated as a key therapy for COVID-19 ARDS. The effects of prone position in critically ill patients with COVID-19 are not fully understood, nor is the optimal time of initiation defined. In this nationwide cohort study, we aimed to investigate the association between early initiation of prone position and mortality in mechanically ventilated COVID-19 patients with low oxygenation on ICU admission.
Using the Swedish Intensive Care Registry (SIR), all Swedish ICU patients ≥ 18 years of age with COVID-19 admitted between March 2020, and April 2021 were identified. A study-population of patients with PaO/FiO ratio ≤ 20 kPa on ICU admission and receiving invasive mechanical ventilation within 24 h from ICU admission was generated. In this study-population, the association between early use of prone position (within 24 h from intubation) and 30-day mortality was estimated using univariate and multivariable logistic regression models.
The total study cohort included 6350 ICU patients with COVID-19, of whom 46.4% were treated with prone position ventilation. Overall, 30-day mortality was 24.3%. In the study-population of 1714 patients with lower admission oxygenation (PaO/FiO ratio ≤ 20 kPa), the utilization of early prone increased from 8.5% in March 2020 to 48.1% in April 2021. The crude 30-day mortality was 27.2% compared to 30.2% in patients not receiving early prone positioning. We found no significant association between early use of prone positioning and survival.
During the first three waves of the COVID-19 pandemic, almost half of the patients in Sweden were treated with prone position ventilation. We found no association between early use of prone positioning and survival in patients on mechanical ventilation with severe hypoxemia on ICU admission. To fully elucidate the effect and timing of prone position ventilation in critically ill patients with COVID-19 further studies are desirable.
COVID-19 急性呼吸窘迫综合征(ARDS)与非 COVID-19 ARDS 具有相似特征,但也表现出明显的生理差异。尽管缺乏强有力的证据,但俯卧位已被提倡作为 COVID-19 ARDS 的关键治疗方法。COVID-19 重症患者俯卧位的效果尚不完全清楚,最佳起始时间也尚未确定。在这项全国性队列研究中,我们旨在研究 COVID-19 患者在 ICU 入院时低氧血症,早期开始俯卧位与死亡率之间的关系。
使用瑞典重症监护注册中心(SIR),确定 2020 年 3 月至 2021 年 4 月期间所有瑞典 ICU 年龄≥18 岁的 COVID-19 患者。生成一个 ICU 入院时 PaO/FiO 比值≤20 kPa 且在 ICU 入院后 24 小时内接受有创机械通气的患者研究人群。在这个研究人群中,使用单变量和多变量逻辑回归模型估计早期使用俯卧位(插管后 24 小时内)与 30 天死亡率之间的关系。
总研究队列包括 6350 例 COVID-19 ICU 患者,其中 46.4%接受俯卧位通气治疗。总体而言,30 天死亡率为 24.3%。在研究人群中,1714 例患者 ICU 入院时氧合较差(PaO/FiO 比值≤20 kPa),早期俯卧位的使用率从 2020 年 3 月的 8.5%增加到 2021 年 4 月的 48.1%。未接受早期俯卧位治疗的患者 30 天死亡率为 27.2%,而接受早期俯卧位治疗的患者 30 天死亡率为 30.2%。我们没有发现早期使用俯卧位与生存之间存在显著关联。
在 COVID-19 大流行的前三个波中,瑞典近一半的患者接受了俯卧位通气治疗。我们发现,在 ICU 入院时严重低氧血症的机械通气患者中,早期使用俯卧位与生存之间没有关联。为了充分阐明 COVID-19 重症患者俯卧位通气的效果和时机,还需要进一步的研究。